Compare Anheuser-Busch Inbev SA (BUD) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Anheuser-Busch Inbev SA vs Hims and Hers Health Inc — how do they compare? Anheuser-Busch Inbev SA trades at $79.97 (market cap $159.01B), while Hims and Hers Health Inc trades at $30.67 (market cap $7.12B). The key difference: Anheuser-Busch Inbev SA is far larger — about 22.3× Hims and Hers Health Inc's market cap, and Anheuser-Busch Inbev SA pays a 1.67% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| BUD | HIMS | |
|---|---|---|
Market Cap | $159.01B | $7.12B |
Sector | Consumer Staples | Health |
52-Week High | $86.48 | $62.76 |
52-Week Low | $57.93 | $14.52 |
Enterprise Value | $223.42B | $7.82B |
Dividend Yield | 1.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Anheuser-Busch Inbev SA
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. After the SABMiller acquisition, the company's portfolio now contains five of the top 10 beer brands by sales and 18 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and U.S.-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev and in 2016 acquired SABMiller.
Read more on BUD →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
